The Oscars is not just a TV event for the company working to sell the commercials that support it. With the annual awards show slated to stream live on Hulu for the first time, alongside its regular ...

The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple ...

VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug ...

VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug ...

Danish pharmaceutical company Lundbeck will buy Longboard Pharmaceuticals (LBPH) in a deal valued at $2.6 billion, with the former hoping to build off of its pipeline of epilepsy drug treatment.

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster. The Danish drugmaker has ...

Denmark’s Lundbeck is bringing a third potential drug for Parkinson’s disease to the clinic – a human antibody that the company hopes will tackle the underlying cause of the condition.

BANGKOK, March 10 (Reuters) - Malaysia has warned its citizens against travelling to southern Thailand after bombings and shootings by suspected insurgents killed five people and injured 13 others ...

Ms Dai has been living in the capital city’s expatriate enclave of Mont Kiara since 2019, after obtaining a Malaysia My Second Home (MM2H) visa that grants her residency for 10 years.

HOW can Malaysia learn from its past to build a better future? This question set the tone at a book talk on How Malaysia Missed 7 Chances at Nation Building by former banker Datuk Mohammed Hussein.

KUALA LUMPUR, Feb 25 (Reuters) - Malaysia had approved investments of 378.5 billion ringgit ($85.8 billion) in 2024, a record figure and an increase of 14.9% from the previous year, its trade ...

Lundbeck in 2019. From November 2015 to May 2018, Mr. Azelby served as executive vice president, chief commercial officer of Juno Therapeutics, Inc. Prior to that, Mr. Azelby served in various ...